Beta-2 Microglobulin

Specialist

also

What it isA small protein found on the surface of nearly all nucleated cells, shed into blood at a steady rate proportional to cell turnover.

DoesActs as a prognostic marker in multiple myeloma and other lymphoid cancers; also reflects kidney.

GoodA low beta-2 microglobulin in a treated myeloma patient signals disease control.

BadElevated beta-2 microglobulin in myeloma predicts worse prognosis. Also rises with chronic inflammation and kidney impairment.

Standard
0.7–1.8 mg/L.
Optimal
0.8–1.5 mg/L (lower is good within range)
Modifiers
Rises with kidney impairment regardless of cancer status.

How to optimize

Lifestyle
Diet
Supplements
Peptides
Drugs
Cancer-directed therapy when indicated.